Construction of glomerular epithelial cells in vitro for removal of immune complex

Journal of Artificial Organs

Volumn 2, Issue 2, 1999, Pages 170-175

  Wang, Pi Chao ^a   Horisawa, Kenichi ^a   Matsumura, Masatoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

CR1 expression; DNA anti DNA antibody; Glomerular epithelial cell; Phagocytosis; Remove immune complex

Indexed keywords

EID: 0348193760     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02480062     Document Type: Article

References (29)

1. Kazatchkine MD, Fearon DT, Appay MD, Mandat C, Briety J. Immunohistochemical study on the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. J Clin Invest 1982;69:900-912
2. Moulds JM, Reveilli JD, Arnett FC. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups. Clin Exp Immunol 1996;105:302-305
3. Arora M, Jain D, Dinda AK, Das SN, Anand V, Tiwari SC, Srivastava LM. Reduced CR1 expression on erythrocytes of idopathic focal-segmental glomerulosclerosis patients. Nephron 1998;79:365-366
4. Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M. Defective immune adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981:2: 493-947
5. Fearon DT, Wong WW. Complement ligand-receptor interactions that mediate idiological responses. Annu Rev Immunol 1983;1: 243-247
6. Klickstein LB, Wong WW, Smith JA, Weis JH, Wilson JG, Fearon DT. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J Exp Med 1987;165:1095-1112
7. Cornacoff JB, Hebert LA, Sead WL, Vanaman ME, Birmingham DJ, Waxman FJ. Primate erythrocyte-immune complex clearing mechanism. J Clin Invest 1983;71:236-247
8. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 1982;156:1739-1754
9. Abrahamson DR, Fearon DT. Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes. Lab Invest 1983;48:162-168
10. Newman SL, Mikus LK, Tucci MA. Differential requirements for cellular cytoskeleton in human macrophage complement receptor-and Fc receptor-mediated phagocytosis. J Immunol 1997;146:967-974
11. Pascual M, Steiger G, Sadallah S, Paccaud J, Carpenter L, Jamers R, Shifferli A. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889-899
12. Kaych M, Hourcade D, Atkinson JP. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci USA 1991;88:4353-4357
13. Weiss L, Fisher E, Cavaillon H, Jouvin MH, Appay MD, Bariety J, Kazatchkine M. The human C3b receptor (CR1). Adv Nephrol Necker Hosp 1989;18:249-269
14. Yamada M, Kawaguchi M, Takamiya H, Wada H, Okigaki T. Establishment and characterization of an epithelial cell line, SGE1, from isolated rat renal glomeruli. Cell Struct Funct 1988;13:495-513
15. Wong WW. Structural and functional correlation of the human complement receptor type I. J Invest Dermatol 1990;64:1531-1546
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. New York: Cold Spring Harbor Laboratory Press, 1989
17. Swanson PC. High resolution epitope mapping of an anti-DNA autoantibody using model DNA ligands. J Immunol 1994;152: 2601-2612
18. Gao Y, Wang PC, Tajima A, Matssumura M. Physical and biological studies on DNA/anti DNA antibody immune complex formed in vitro. Cytotechnology 1997;25:165-171
19. Swanson PC, Ackroyd C, Click GD. Ligand-recognition by anti-DNA autoantibodies. Affinity specificity, and mode of binding. Biochemistry 1996;35:1624-1633
20. Stevens SY, Swanson PC, Glick GD. Application of the gel shift assay to study the affinity and specificity of anti-DNA autoantibodies. J Immunol Meth 1994;172:185-190
21. Taylor RP, Burge J, Horgan C, Shabby M. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils. J Immunol 1983;130:2656-2662
22. Winkler TH, Jahn S, Kalden JR. IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1991;85:379-385
23. Michael P, Madaio, Hodder S, Schwartz RS, Stollar BD. Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 1984;132:872-876
24. Boackle SA, Morris MA, Holers VM. Karp DR. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998;161:6537-6543
25. Marve M, Moxey M, Bernice N. Glomerular macrophage phagocytic activity in experimental immune complex nephrits Kidney Int 1994;45:1326-1332
26. Kessary SH, Naot Y, Gershon H. Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytes. Clin Exp Immunol 1998;113:77-84
27. Huw LC, Beynon A, Haskard O, Walport M. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophiles and endothelium. J Immunol 1994;153: 3160-3167
28. Yoshida K, Van-den-Berg TK, Dijkstra CD. Two functionally different follicular dendritic cells in secondary lymphoid follicles of mouse spleen, as revealed by CR1/2 and FcR gamma II-mediated immune complex trapping. Immunology 1993;80:34-39
29. Bariety J, Nochy D, Namdet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagicassociated marker in idiopathic collapsing glomerulopathy. Kidney Int 1998;53:918-925